Wayland Group Corp.

MRRC.F

CA9442041062

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 10:45:57 2024-04-26 am EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2021	RG5 Investments Inc. and Albert Sheeler cancelled the acquisition of Gardina Pharmaceutical SAS from Wayland Group Corp..	CI
2020	Wayland Group Corp. Announces Board and CEO Resignation	CI

Maricann Group Inc. cancelled the acquisition of Colma Pharmaceutical SAS on November 6, 2019.

November 05, 2019

Maricann Group Inc. (CNSX:WAYL) agreed to acquire Colma Pharmaceutical SAS for 16.5 million on November 6, 2018. As a part of consideration, Maricann Group Inc. will issue 11 million common shares with a deemed price of CAD 2.00 per share. Maricann Group Inc. (CNSX:WAYL) cancelled the acquisition of Colma Pharmaceutical SAS on November 6, 2019.

Latest news about Wayland Group Corp.

RG5 Investments Inc. and Albert Sheeler cancelled the acquisition of Gardina Pharmaceutical SAS from Wayland Group Corp..	21-02-01	CI
Wayland Group Corp. Announces Board and CEO Resignation	20-04-23	CI
CanAdelaar B.V. completed the acquisition of Maricann Inc. and certain certain other property from Wayland Group Corp. and Nanoleaf Technologies Inc.	20-04-22	CI
CanAdelaar B.V. agreed to acquire Maricann Inc. and certain certain other property from Wayland Group Corp. and Nanoleaf Technologies Inc. for CAD 12.4 million.	20-04-08	CI
RG5 Investments Inc. and Albert Sheeler agreed to acquire Gardina Pharmaceutical SAS from Wayland Group Corp. for CAD 0.3 million.	20-02-12	CI
Wayland Group Corp. Announces Management Changes	20-01-12	CI
Wayland Announces Court Approval of Amended DIP Facility	19-12-15	CI
Wayland Group cancelled the acquisition of 97% stake in Agro Ivica Dumandzic S.R.L.	19-12-09	CI
Maricann Group Inc. cancelled the acquisition of 51% stake in Theros Pharma Ltd.	19-12-04	CI
Wayland Group Corp. cancelled the acquisition of 50.1% stake in Tropicana Pty Ltd.	19-12-02	CI
ICC International Cannabis Corp. (CNSX:WRLD.U) cancelled the acquisition of 49.9% stake in Maricann B.V. from Wayland Group Corp..	19-11-12	CI
Maricann Group Inc. cancelled the acquisition of Colma Pharmaceutical SAS on November 6, 2019.	19-11-05	CI
Wayland Group Corp. Provides Corporate Update on Transaction, Construction and Operational Progress; Revises Revenue Guidance for 2019; Plans to Plan New Plants	19-10-31	CI
Wayland Group Receives $5 Million Bridge Loan from Cryptologic	19-08-09	CI
Wayland Group Corp. Announces Executive Changes	19-08-02	CI
Wayland Group Announces Changes to the Board of Directors	19-07-08	CI
Wayland Group Corp. Announces Delay in Filing in Audited Annual Financial Statements for the Year Ended December 31, 2018	19-04-30	CI
Wayland Group Names Matthew McLeod as President	19-04-23	CI
Wayland Group Corp. announced that it has received CAD 20 million in funding from European High Growth Opportunities Manco S.A.	19-04-11	CI
Wayland Group Announces Resignation of Rudi Hilti as Director	19-04-09	CI
Wayland Group Announces its Selection as One of Three Groups, Pending Review Period, for Cannabis Production Licenses in Germany	19-04-04	CI
Wayland Group Corp. Announce Resignation of Eric Silver Has Resigned as Director	19-02-22	CI
Wayland Group Corp. Announces Resignation of Michael Stein as Director	19-02-21	CI
Wayland Group Corp. Provides Corporate Update on its Operational Progress in Canada and Internationally; Provides Revenue Guidance for the First Quarter, Second Quarter, Third Quarter and Fourth Quarter of 2019	19-02-20	CI
Wayland Group Receives EU-GMP Certification for German Facility	19-02-07	CI

Chart Wayland Group Corp.

Duration

Period

More charts

Company Profile

Wayland Group Corp, formerly Maricann Group Inc, is a Canada-based vertically integrated cultivator and processor of cannabis. The Company has production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation, and distribution business under federal licenses from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany, Regensdorf, Switzerland, Allesandria, Piedmont, Italy and Ibague, Colombia.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
WAYLAND GROUP CORP.	0.00%	237
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B

Alternative Medicine

Wayland Group Corp.

Equities

MRRC.F

CA9442041062

Pharmaceuticals

Maricann Group Inc. cancelled the acquisition of Colma Pharmaceutical SAS on November 6, 2019.

Latest news about Wayland Group Corp.

Chart Wayland Group Corp.

Company Profile

Sector Alternative Medicine